Cure's Landmark Report Reveals 87% of Healthcare Leaders Remain Optimistic About the Future, Despite Challenges

NEW YORK, June 16, 2025 /PRNewswire/ -- Cure, a premier healthcare innovation ecosystem headquartered in New York City, today released the The Future of Healthcare Innovation 2025, a landmark report capturing the surprising results of a CEO survey that shows despite policy shifts and funding uncertainty, 87 percent of healthcare leaders remain optimistic about the future of the biotech industry. The report, reflecting opinions, concerns, and strategies of leading entrepreneurs, investors, academics, and government stakeholders, paints a picture of an industry evolving in real-time and meeting the moment not with paralysis but with purpose and ingenuity.

"Disruption can be a powerful catalyst for change — entrepreneurs are adapting, not retreating," said Seema Kumar, CEO of Cure. "The data and insights captured in The Future of Healthcare Innovation 2025 reveal that healthcare leaders are responding with bold ideas and smart pivots to rethink how breakthroughs can move from discoveries into real-world impact."

Cure developed the report using data from a May 2025 Cure survey of more than 100 CEOs and senior executives across the healthcare sector and interviews with select leaders. Cure conducted this survey in partnership with the Deerfield Institute, a division of Deerfield Management Company, an affiliate of Cure.

How are Healthcare Leaders Navigating This Moment of Uncertainty?

The top 10 findings from Cure's report include:

• 87% of respondents remain optimistic about the industry's future, despite headwinds.
• 61% of respondents predict the biotech industry will grow this year.
• Access to capital and regulatory clarity remain the top drivers of success.
• Federal budget cuts, FDA delays, and tariffs are reshaping R&D timelines, supply chains, and talent recruitment.
• 87% of respondents predict federal cuts will negatively impact biotech innovation.
• Policy now outranks technology as the biggest healthcare disruptor.
• AI and private capital are critical levers to retain America's innovation edge.
• Oncology, immunology, infectious diseases, and neurology have the largest unmet need and the greatest opportunity for investment.
• Women's health investments remain resilient, although funding levels are not sufficient.
• AI, machine learning, and cell and gene therapies topped the list of tools driving scientific discovery, reshaping business models, attracting investment, and expanding access.

Six Actions for Healthcare Founders and Investors to Take Now

"We are at a pivotal moment," said Kumar. "The foundational systems and infrastructure that support the healthcare innovation ecosystem are undergoing fundamental, end-to-end transformation. Our report is both a call to action and a roadmap for leaders who want to navigate the disruption and shape the future of healthcare."

The report offers six strategic actions every healthcare leader, founder, and entrepreneur should consider now.

1. Rethink regulatory strategy
2. Use AI to work smarter
3. Fortify supply chains before they break
4. Rethink funding strategies to leverage private capital
5. Retain core talent and recruit strategically from federal exits.
6. Support the healthcare ecosystem that entrepreneurs need to thrive.

To read the full report, visit: wewillcure.com/insights/healthcare-innovation-report.

About Cure

Cure is a premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop their groundbreaking products and services from concept to commercialization. Cure's thriving NYC campus includes state-of-the-art research and business facilities, and its digital ecosystem serves as the go-to resource for health innovators. Its dedicated content hub offers expert-driven insights, resources, mentoring, networking, and business services. The on-campus Cure Collaboration Residency companies include startups and established enterprises. Cure also hosts and convenes flagship events and conferences, bringing together thought leaders from across sectors in its premium venues, including an education center, conference center, and an iconic rooftop. For more information, please visit wewillcure.com.

SOURCE Cure